Preventive Pap-smears: balancing costs, risks and benefits
- PMID: 1616867
- PMCID: PMC1977773
- DOI: 10.1038/bjc.1992.195
Preventive Pap-smears: balancing costs, risks and benefits
Abstract
The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too many women overscreened or unprotected. The combination in young age of a low incidence of invasive cancer and a high incidence of regressive lesions explains relative ineffectiveness and harmfulness of present screening practice. When screening would take place between ages 30 and at least 60, with intervals of about 5 years, as many lives could be saved for half the costs and with only 60% of the unnecessary referrals and treatments. Much attention should be paid to the coverage of the target population. Therapeutic follow-up policies for dysplastic lesions should be restrained.
Similar articles
-
Cost-effective policies for cervical cancer screening. An international review.Pharmacoeconomics. 1996 Mar;9(3):211-30. doi: 10.2165/00019053-199609030-00004. Pharmacoeconomics. 1996. PMID: 10160098 Review.
-
Cost-effectiveness of cervical cancer screening: comparison of screening policies.J Natl Cancer Inst. 2002 Feb 6;94(3):193-204. doi: 10.1093/jnci/94.3.193. J Natl Cancer Inst. 2002. PMID: 11830609
-
The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.J Med Screen. 2002;9(2):86-91. doi: 10.1136/jms.9.2.86. J Med Screen. 2002. PMID: 12133929
-
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.J Natl Cancer Inst. 2016 Oct 18;109(2):djw216. doi: 10.1093/jnci/djw216. Print 2017 Feb. J Natl Cancer Inst. 2016. PMID: 27754955 Free PMC article.
-
[Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1569-71. Ned Tijdschr Geneeskd. 2002. PMID: 12224477 Review. Dutch.
Cited by
-
The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.Pharmacoeconomics. 1996 Aug;10(2):141-51. doi: 10.2165/00019053-199610020-00006. Pharmacoeconomics. 1996. PMID: 10163417 Clinical Trial.
-
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.Br J Cancer. 1997;76(5):651-7. doi: 10.1038/bjc.1997.440. Br J Cancer. 1997. PMID: 9303366 Free PMC article.
-
Analysis of the Excess of Papanicolaou Tests in Brazil from 2006 to 2015.Rev Bras Ginecol Obstet. 2022 Jan;44(1):40-46. doi: 10.1055/s-0041-1741407. Epub 2022 Jan 29. Rev Bras Ginecol Obstet. 2022. PMID: 35092958 Free PMC article.
-
Cost-effective policies for cervical cancer screening. An international review.Pharmacoeconomics. 1996 Mar;9(3):211-30. doi: 10.2165/00019053-199609030-00004. Pharmacoeconomics. 1996. PMID: 10160098 Review.
-
PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes.J Clin Pathol. 2000 Aug;53(8):606-11. doi: 10.1136/jcp.53.8.606. J Clin Pathol. 2000. PMID: 11002764 Free PMC article.